Annora Pharma Private Limited: Lacosamide Tablets, Usp, C V, 100mg

Recall Summary Annora Pharma is recalling Lacosamide Tablets USP 100mg (NDC 31722-813-60) distributed nationwide because some bottles may contain Selexipag 1000 mcg tablets mixed in by mistake. The recalled product is a prescription seizure medication manufactured for Camber Pharmaceuticals and distributed across all U.S. states.

Recalling firm
Annora Pharma Private Limited
Product
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Reason
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-06-04
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
Nationwide in the USA

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/239c684a-d345-4520-8c3f-57f7129fc504